113 related articles for article (PubMed ID: 8563492)
1. Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor.
Renz H; Bradley K; Enssle K; Loader JE; Larsen GL; Gelfand EW
Int Arch Allergy Immunol; 1996 Feb; 109(2):167-76. PubMed ID: 8563492
[TBL] [Abstract][Full Text] [Related]
2. Nebulized but not parenteral IFN-gamma decreases IgE production and normalizes airways function in a murine model of allergen sensitization.
Lack G; Renz H; Saloga J; Bradley KL; Loader J; Leung DY; Larsen G; Gelfand EW
J Immunol; 1994 Mar; 152(5):2546-54. PubMed ID: 8133062
[TBL] [Abstract][Full Text] [Related]
3. Development and transfer of immediate cutaneous hypersensitivity in mice exposed to aerosolized antigen.
Saloga J; Renz H; Lack G; Bradley KL; Greenstein JL; Larsen G; Gelfand EW
J Clin Invest; 1993 Jan; 91(1):133-40. PubMed ID: 8423213
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment with allergen prevents immediate hypersensitivity and airway hyperresponsiveness.
Oshiba A; Hamelmann E; Bradley KL; Loader JE; Renz H; Larsen GL; Gelfand EW
Am J Respir Crit Care Med; 1996 Jan; 153(1):102-9. PubMed ID: 8542101
[TBL] [Abstract][Full Text] [Related]
5. Increased airways responsiveness in mice depends on local challenge with antigen.
Saloga J; Renz H; Larsen GL; Gelfand EW
Am J Respir Crit Care Med; 1994 Jan; 149(1):65-70. PubMed ID: 8111600
[TBL] [Abstract][Full Text] [Related]
6. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice.
Oshiba A; Hamelmann E; Takeda K; Bradley KL; Loader JE; Larsen GL; Gelfand EW
J Clin Invest; 1996 Mar; 97(6):1398-408. PubMed ID: 8617871
[TBL] [Abstract][Full Text] [Related]
7. Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma.
Henderson WR; Chi EY; Maliszewski CR
J Immunol; 2000 Jan; 164(2):1086-95. PubMed ID: 10623860
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic interference with interferon-gamma (IFN-gamma) and soluble IL-4 receptor (sIL-4R) in allergic diseases.
Nasert S; Millner M; Herz U; Lack G; Wahn U; Gelfand EW; Renz H
Behring Inst Mitt; 1995 Jun; (96):118-30. PubMed ID: 7575347
[TBL] [Abstract][Full Text] [Related]
9. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor].
Knöchel B; Luttmann W; Kroegel C
Pneumologie; 1996 Aug; 50(8):569-70. PubMed ID: 8975249
[No Abstract] [Full Text] [Related]
11. Transfer of immediate hypersensitivity and airway hyperresponsiveness by IgE-positive B cells.
Lack G; Oshiba A; Bradley KL; Loader JE; Amran D; Larsen GL; Gelfand EW
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1765-73. PubMed ID: 8520735
[TBL] [Abstract][Full Text] [Related]
12. Various immunological phenotypes are associated with increased airway responsiveness.
Herz U; Braun A; Rückert R; Renz H
Clin Exp Allergy; 1998 May; 28(5):625-34. PubMed ID: 9645600
[TBL] [Abstract][Full Text] [Related]
13. Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness--a murine model.
Hamelmann E; Tadeda K; Oshiba A; Gelfand EW
Allergy; 1999 Apr; 54(4):297-305. PubMed ID: 10371087
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the allergenicity of ovalbumin and ovalbumin peptide 323-339. Differential expansion of V beta-expressing T cell populations.
Renz H; Bradley K; Larsen GL; McCall C; Gelfand EW
J Immunol; 1993 Dec; 151(12):7206-13. PubMed ID: 8258720
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization.
Renz H; Lack G; Saloga J; Schwinzer R; Bradley K; Loader J; Kupfer A; Larsen GL; Gelfand EW
J Immunol; 1994 Jan; 152(1):351-60. PubMed ID: 8254203
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of allergen-induced IgE and IgG1 production by soluble IL-4 receptor.
Renz H; Enssle K; Lauffer L; Kurrle R; Gelfand EW
Int Arch Allergy Immunol; 1995 Jan; 106(1):46-54. PubMed ID: 7812166
[TBL] [Abstract][Full Text] [Related]
17. Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness.
Hamelmann E; Oshiba A; Schwarze J; Bradley K; Loader J; Larsen GL; Gelfand EW
Am J Respir Cell Mol Biol; 1997 Jun; 16(6):674-82. PubMed ID: 9191469
[TBL] [Abstract][Full Text] [Related]
18. Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness.
Hamelmann E; Cieslewicz G; Schwarze J; Ishizuka T; Joetham A; Heusser C; Gelfand EW
Am J Respir Crit Care Med; 1999 Sep; 160(3):934-41. PubMed ID: 10471622
[TBL] [Abstract][Full Text] [Related]
19. Para-Bromophenacyl bromide alleviates airway hyperresponsiveness and modulates cytokines, IgE and eosinophil levels in ovalbumin-sensitized and -challenged mice.
Ram A; Das M; Gangal SV; Ghosh B
Int Immunopharmacol; 2004 Dec; 4(13):1697-707. PubMed ID: 15454121
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the development of immediate hypersensitivity by staphylococcal enterotoxin B.
Saloga J; Lack G; Bradley K; Renz H; Larsen G; Leung DY; Gelfand EW
Eur J Immunol; 1994 Dec; 24(12):3140-7. PubMed ID: 7805743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
